Skip to main content

ALG9

Multi tool use
Multi tool use








ALG9


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search





























































ALG9
Identifiers
Aliases
ALG9, CDG1L, DIBD1, LOH11CR1J, alpha-1,2-mannosyltransferase, GIKANIS
External IDs MGI: 1924753 HomoloGene: 6756 GeneCards: ALG9


















Gene location (Human)
Chromosome 11 (human)
Chr. Chromosome 11 (human)[1]

Chromosome 11 (human)
Genomic location for ALG9

Genomic location for ALG9

Band 11q23.1 Start 111,782,195 bp[1]
End 111,871,581 bp[1]























RNA expression pattern
PBB GE ALG9 219374 s at fs.png
More reference expression data















Orthologs
Species Human Mouse
Entrez


79796


102580
Ensembl


ENSG00000086848


ENSMUSG00000032059
UniProt


Q9H6U8


Q8VDI9
RefSeq (mRNA)





NM_133981
RefSeq (protein)





NP_598742
Location (UCSC) Chr 11: 111.78 – 111.87 Mb Chr 9: 50.78 – 50.84 Mb

PubMed search		 [3] [4]
Wikidata



View/Edit Human View/Edit Mouse

Alpha-1,2-mannosyltransferase ALG9 is an enzyme that in humans is encoded by the ALG9 gene.[5][6][7]





References[edit]





  1. ^ abc GRCh38: Ensembl release 89: ENSG00000086848 - Ensembl, May 2017


  2. ^ abc GRCm38: Ensembl release 89: ENSMUSG00000032059 - Ensembl, May 2017


  3. ^ "Human PubMed Reference:"..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"""""""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}


  4. ^ "Mouse PubMed Reference:".


  5. ^ Baysal BE, Willett-Brozick JE, Badner JA, Corona W, Ferrell RE, Nimgaonkar VL, Detera-Wadleigh SD (May 2002). "A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family". Neurogenetics. 4 (1): 43–53. doi:10.1007/s10048-001-0129-x. PMID 12030331.


  6. ^ Frank CG, Grubenmann CE, Eyaid W, Berger EG, Aebi M, Hennet T (May 2004). "Identification and Functional Analysis of a Defect in the Human ALG9 Gene: Definition of Congenital Disorder of Glycosylation Type IL". Am J Hum Genet. 75 (1): 146–50. doi:10.1086/422367. PMC 1181998. PMID 15148656.


  7. ^ "Entrez Gene: ALG9 asparagine-linked glycosylation 9 homolog (S. cerevisiae, alpha- 1,2-mannosyltransferase)".




Further reading[edit]


.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}



  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.


  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.


  • Hartley JL, Temple GF, Brasch MA (2001). "DNA Cloning Using In Vitro Site-Specific Recombination". Genome Res. 10 (11): 1788–95. doi:10.1101/gr.143000. PMC 310948. PMID 11076863.


  • Wiemann S, Weil B, Wellenreuther R, et al. (2001). "Toward a Catalog of Human Genes and Proteins: Sequencing and Analysis of 500 Novel Complete Protein Coding Human cDNAs". Genome Res. 11 (3): 422–35. doi:10.1101/gr.GR1547R. PMC 311072. PMID 11230166.


  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.


  • Hendricks TJ, Fyodorov DV, Wegman LJ, et al. (2003). "Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior". Neuron. 37 (2): 233–47. doi:10.1016/S0896-6273(02)01167-4. PMID 12546819.


  • Xu X, Stern DF (2003). "NFBD1/MDC1 regulates ionizing radiation-induced focus formation by DNA checkpoint signaling and repair factors". FASEB J. 17 (13): 1842–8. doi:10.1096/fj.03-0310com. PMID 14519663.


  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.


  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.


  • Wiemann S, Arlt D, Huber W, et al. (2004). "From ORFeome to Biology: A Functional Genomics Pipeline". Genome Res. 14 (10B): 2136–44. doi:10.1101/gr.2576704. PMC 528930. PMID 15489336.


  • Weinstein M, Schollen E, Matthijs G, et al. (2005). "CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features". Am. J. Med. Genet. A. 136 (2): 194–7. doi:10.1002/ajmg.a.30851. PMID 15945070.


  • Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.


  • Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.


  • Mehrle A, Rosenfelder H, Schupp I, et al. (2006). "The LIFEdb database in 2006". Nucleic Acids Res. 34 (Database issue): D415–8. doi:10.1093/nar/gkj139. PMC 1347501. PMID 16381901.




External links[edit]



  • GeneReviews/NCBI/NIH/UW entry on Congenital Disorders of Glycosylation Overview

  • Human ALG9 genome location and ALG9 gene details page in the UCSC Genome Browser.















Retrieved from "https://en.wikipedia.org/w/index.php?title=ALG9&oldid=797877437"





Navigation menu

























(window.RLQ=window.RLQ||).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.568","walltime":"0.678","ppvisitednodes":{"value":1098,"limit":1000000},"ppgeneratednodes":{"value":0,"limit":1500000},"postexpandincludesize":{"value":124875,"limit":2097152},"templateargumentsize":{"value":15670,"limit":2097152},"expansiondepth":{"value":7,"limit":40},"expensivefunctioncount":{"value":21,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":38057,"limit":5000000},"entityaccesscount":{"value":22,"limit":400},"timingprofile":["100.00% 560.940 1 -total"," 60.11% 337.165 1 Template:Infobox_gene"," 23.37% 131.118 16 Template:Cite_journal"," 18.86% 105.776 1 Template:PBB_Further_reading"," 8.44% 47.348 1 Template:Reflist"," 8.14% 45.654 4 Template:Navbox"," 6.12% 34.309 1 Template:Glycosyltransferases"," 2.27% 12.735 1 Template:Gene-11-stub"," 2.05% 11.502 1 Template:Refbegin"," 1.82% 10.227 1 Template:Asbox"]},"scribunto":{"limitreport-timeusage":{"value":"0.406","limit":"10.000"},"limitreport-memusage":{"value":6729897,"limit":52428800}},"cachereport":{"origin":"mw1243","timestamp":"20181024011637","ttl":1900800,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":776,"wgHostname":"mw1243"});});9m1hewh,xwECzZKPeYdnPeyh,sgmXNVXkFY,VRo2 VgA KIkYUqGNZbtB60yDxH5NCXRqb39KYp3S5,D1dzeBf,GS,a6xAePiv
-
iX 88F,61M 8svAR6lXNNR,EsEuiMQzZHXVYMB,WQC7,z7lJpFaPD w lud3Len04jo XU7SMwwv3SE,Ql

Popular posts from this blog

Full-time equivalent

Image
Full-time equivalent From Wikipedia, the free encyclopedia Jump to navigation Jump to search Full-time equivalent ( FTE ) or whole time equivalent ( WTE ) is a unit that indicates the workload of an employed person (or student) in a way that makes workloads or class loads comparable [1] across various contexts. FTE is often used to measure a worker's or student's involvement in a project, or to track cost reductions in an organization. An FTE of 1.0 is equivalent to a full-time worker or student, while an FTE of 0.5 signals half of a full work or school load. [2] Contents 1 U.S. Federal Government 2 In education 2.1 Example 3 Notes 4 References U.S. Federal Government [ edit ] In the U.S. Federal Government, FTE is defined by the Government Accountability Office (GAO) as the number of total hours worked divided by the maximum number of compensable hours in a full-time schedule as...
Read more

Haven (TV series)

Image
Haven (TV series) From Wikipedia, the free encyclopedia Jump to navigation Jump to search Haven Genre Supernatural drama Based on The Colorado Kid by Stephen King Developed by Sam Ernst Jim Dunn Starring Emily Rose Lucas Bryant Nicholas Campbell Eric Balfour Theme music composer Andre Fratto Leah Siegel Composer(s) Shawn Pierce Country of origin United States Canada Original language(s) English No. of seasons 5 No. of episodes 78 (list of episodes) Production Executive producer(s) Sam Ernst Jim Dunn David MacLeod John Morayniss Noreen Halpern Laszlo Barna Gabrielle Stanton Matt McGuiness Scott Shepherd Shawn Piller Lloyd Segan Production location(s) Nova Scotia, Canada Cinematography Eric Cayla Barry Donlevy Camera setup single Running time 41–43 minutes Production company(s) Big Motion Pictures Production...
Read more

さくらももこ

Image
さくら ももこ 本名 非公開 [1] 生誕 ( 1965-05-08 ) 1965年5月8日 日本・静岡県清水市 （現・静岡市清水区） 死没 ( 2018-08-15 ) 2018年8月15日（53歳没） 日本・東京都目黒区 国籍 日本 職業 漫画家 エッセイスト 作詞家 活動期間 1984年 - 2018年 ジャンル 少女漫画 青年漫画 児童漫画 代表作 『ちびまる子ちゃん』 『コジコジ』 受賞 1989年：第13回講談社漫画賞少女部門 （『ちびまる子ちゃん』） 1990年：第32回日本レコード大賞 （『おどるポンポコリン』作詞） 公式サイト さくらプロダクション テンプレートを表示 さくら ももこ （1965年5月8日 - 2018年8月15日 [2] ）は、日本の漫画家、エッセイスト、作詞家、脚本家。また、自身の少女時代をモデルとした代表作のコミック『ちびまる子ちゃん』の主人公の名前でもある。静岡県清水市（現・静岡市清水区）出身。血液型はA型。身長159cm。一男の母親。 代表作のコミック『ちびまる子ちゃん』の単行本の売上は累計3000万部を超える。また、エッセイストとしても独特の視点と語り口で人気が高く、初期エッセイ集三部作『もものかんづめ』『さるのこしかけ』『たいのおかしら』はいずれもミリオンセラーを記録。 目次 1 経歴 2 人物・交遊関係 3 主な作品 3.1 漫画 3.2 エッセイ 3.3 作詞 3.4 詩集 3.5 雑誌・ムック本 3.6 翻訳 3.7 絵本、ドラマ脚本他 3.8 ラジオ出演 3.9 その他 4 関係人物 4.1 アシスタント 4.2 さくらももこを演じた人物 5 脚注 5.1 注釈 5.2 出典 6 外部リンク 経歴 年譜形式の経歴は推奨されていません 。人物の伝記は流れのあるまとまった文章で記述し、年譜は補助的な使用にとどめてください。 （ 2018年8月 ） 清水市立（当時）入江小学校...
Read more